title: Etiologic study of genitourinary infections in women of childbearing age in Bobo-Dioulasso, Burkina Faso, 1992.
abstract: OBJECTIVE
  Genitourinary infections have a major impact on public health, especially in Africa. Relative distribution of the different pathogens is unknown in Bobo-Dioulasso.
  
  
  OBJECTIVE
  To describe the etiology of genitourinary infections, to establish the sensitivity of Neisseria gonorrhoeae to antibiotics, and to provide epidemiologic and biologic evidence to optimize the treatment of genitourinary infections.
  
  
  METHODS
  Clinical and biologic diagnoses were performed on 223 women with genitourinary infections.
  
  
  RESULTS
  Etiologies found were trichomoniasis (27.8%), chlamydia (26.9%), bacterial vaginosis (19.7%), candidiasis (16.6), and N. gonorrhoeae infection (10.9%). Human immune deficiency virus antibodies were present in 42% of the patients. Spectinomycin or ceftriaxone should be recommended for the treatment of gonorrhoeae in Bobo-Dioulasso.
  
  
  CONCLUSIONS
  The prevalence of Chlamydia trachomatis is higher than that of N. gonorrhoeae in Bobo-Dioulasso. This should be taken into account in clinical management of sexually transmitted diseases in this setting.
authors.affiliation: Centre Muraz/Organisation de Coordination et de Coopération pour la lutte contre les Grandes Endémies, Bobo-Dioulasso, Burkina Faso.
authors.forename: S
authors.initials: S
authors.lastname: Ledru
authors.forename: N
authors.initials: N
authors.lastname: Meda
authors.forename: M
authors.initials: M
authors.lastname: Fofana
authors.forename: G
authors.initials: G
authors.lastname: Soula
authors.forename: A J
authors.initials: AJ
authors.lastname: Bazié
authors.forename: J P
authors.initials: JP
authors.lastname: Chiron
mesh_terms: D000293:Adolescent; D000328:Adult; D000818:Animals; D002050:Burkina Faso / Q000453:epidemiology; D002181:Candidiasis, Vulvovaginal / Q000453:epidemiology; D016009:Chi-Square Distribution; D002690:Chlamydia Infections / Q000453:epidemiology; D002692:Chlamydia trachomatis / Q000302:isolation & purification; D004352:Drug Resistance, Microbial; D005260:Female; D052776:Female Urogenital Diseases / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology*; D006194:Gardnerella vaginalis / Q000302:isolation & purification; D006069:Gonorrhea / Q000188:drug therapy / Q000453:epidemiology; D015658:HIV Infections / Q000453:epidemiology; D006801:Humans; D008875:Middle Aged; D009344:Neisseria gonorrhoeae / Q000187:drug effects / Q000302:isolation & purification; D012959:Socioeconomic Factors; D018709:Statistics, Nonparametric; D013587:Syphilis / Q000453:epidemiology; D014245:Trichomonas Infections / Q000453:epidemiology; D014246:Trichomonas vaginalis / Q000302:isolation & purification; D016585:Vaginosis, Bacterial / Q000453:epidemiology